Akebia Therapeutics (AKBA) FCF Margin Growth (1y) (2018 - 2026)
Akebia Therapeutics (AKBA) FCF Margin Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 427.00 |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 325.00 |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -892.00 |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 1,003.00 |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 410.00 |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 39.00 |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 333.00 |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Akebia Therapeutics | 244.72 Mn | 89.17 Mn | 38.70 Mn | -2,907.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2,907.00 |
| Mar 31, 2026 | -1,728.00 |
| Dec 31, 2025 | 5,806.00 |
| Sep 30, 2025 | 6,687.00 |
| Jun 30, 2025 | 5,619.00 |
| Mar 31, 2025 | 3,775.00 |
| Dec 31, 2024 | -1,864.00 |
| Sep 30, 2024 | 1,731.00 |
| Jun 30, 2024 | -3,205.00 |
| Mar 31, 2024 | -1,061.00 |
| Dec 31, 2023 | 10,846.00 |
| Sep 30, 2023 | -8,510.00 |
| Jun 30, 2023 | 3,090.00 |
| Mar 31, 2023 | 2.32 Mn |
| Dec 31, 2022 | -13,932.00 |
| Sep 30, 2022 | 17,265.00 |
| Jun 30, 2022 | 9,458.00 |
| Mar 31, 2022 | -2.31 Mn |
| Dec 31, 2021 | 16,370.00 |
| Sep 30, 2021 | 10,137.00 |